Vancouver Island drug company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from 27 countries living with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Aurinia co-founder Mike Martin noted that after eight years of hard work, staff are excited about the outcomes of the trial. he emphasized that the drug’s success will be significant for people living with lupus – close to 1 million people worldwide.

“It was a pleasure to share the results,” Martin said. Given the data, he wasn’t surprised by the uptake in stock.

He emphasized how grateful the company is for the participants and for the opportunity to change the trajectory of people’s lives.

The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Just Posted

BREAKING NEWS: Coulson Aviation C-130 crashes in Australia

Three people are confirmed dead in the crash in New South Wales

B.C. RCMP spent roughly $750K on massive manhunt for Schmegelsky, McLeod

Manitoba RCMP helped with 17-day search through the province’s northern terrain

Child struck by vehicle in front of elementary school in Nanaimo

Six-year-old girl taken to Nanaimo Regional General Hospital with non life-threatening injuries

Successful end to search for kayakers along the Chemainus River

Father and son located tired and cold, but otherwise OK

One year later: Theo the giant pig settling into Sahtlam sanctuary

“He’s doing really well, lost quite a few pounds and can run now.”

Four things ‘not’ to do if you run into Prince Harry and Meghan in B.C.

Here is a list of some things you definitely should NOT do, according to the BBC

Rainfall warning issued for east Vancouver Island

Warning issued for area from Nanoose Bay to Campbell River

New nasal spray launched in Canada to combat hypoglycemic shock in diabetics

Baqsimi is a nasal spray contains three milligrams of glucagon

Island Bakery in Cobble Hill to close

Cobble Hill store in business since 1982

Vancouver Island man arrested after police seize suspected illicit drugs in Nanoose Bay

Car impounded after Port Alberni driver clocked travelling at more than twice the posted speed limit

All Carlton Cards stores closing in the coming weeks

Schurman Retail Group stores across North America will close, including 79 in Canada

Nanaimo RCMP looking for man suspected of $25,000 credit fraud

Police allege suspect racked up debt under another person’s name

Man killed by police in Lytton called 911, asking to be shot: RCMP

Howard Schantz, also known as Barry Schantz was killed following a standoff at his Lytton home

Most Read